Evidence map›Paper›PMID 33374121›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Carbapenem-Resistant

Tomasz Bogiel, Małgorzata Prażyńska, Joanna Kwiecińska-Piróg, Agnieszka Mikucka, Eugenia Gospodarek-Komkowska

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Virulence and Resistance ofMicroorganisms · 2025
    Article
  3. Article
  4. Article
  5. Does Every Strain ofPathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Decoding Genetic Features and Antimicrobial Susceptibility ofInternational journal of molecular sciences · 2022
    Article
  9. Targeting theFrontiers in microbiology · 2022
    Article
  10. Article
  11. Evaluation of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tomasz BogielMicrobiology Department, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.
Małgorzata PrażyńskaMicrobiology Department, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.
Joanna Kwiecińska-PirógMicrobiology Department, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.ORCID 0000-0003-1476-3263
Agnieszka MikuckaMicrobiology Department, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.
Eugenia Gospodarek-KomkowskaMicrobiology Department, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 9 Maria Skłodowska-Curie Street, 85-094 Bydgoszcz, Poland.
Nicolaus Copernicus University · PL

Funding

Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Toruń UPB 2019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carbapenem-resistant Pseudomonas aeruginosacarbapenemsPseudomonas aeruginosaPseudomonas aeruginosa genotypesPseudomonas aeruginosa virulenceresistance to carbapenemsvirulencevirulence factor genes

Identifiers

PMID33374121
PMCPMC7823804
OpenAlexW3115885194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.